Results 131 to 140 of about 5,975,260 (378)

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Machine-Learned Codes from EHR Data Predict Hard Outcomes Better than Human-Assigned ICD Codes

open access: yesMachine Learning and Knowledge Extraction
We used machine learning (ML) to characterize 894,154 medical records of outpatient visits from the Veterans Administration Central Data Warehouse (VA CDW) by the likelihood of assignment of 200 International Classification of Diseases (ICD) code blocks.
Ying Yin   +4 more
doaj   +1 more source

Blocking sets, minimal codes and trifferent codes

open access: yesJournal of the London Mathematical Society
AbstractWe prove new upper bounds on the smallest size of affine blocking sets, that is, sets of points in a finite affine space that intersect every affine subspace of a fixed codimension. We show an equivalence between affine blocking sets with respect to codimension‐2 subspaces that are generated by taking a union of lines through the origin, and ...
Bishnoi, A. (author)   +3 more
openaire   +3 more sources

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy